Mice given a bile acid made by the gut bacterium Ruminococcus gnavus developed blood fat disturbances.Mice given a bile acid made by the gut bacterium Ruminococcus gnavus developed blood fat disturbances.
Compared with other schedules, day-shift work was linked to a lower relative rate of major cardiovascular events—a hazard ratio of 0.78 over a median 3.3 years.Compared with other schedules, day-shift work was linked to a lower relative rate of major cardiovascular events—a hazard ratio of 0.78 over a median 3.3 years.
Compared with less muscle, greater muscle area was linked to lower relative heart failure risk, with a hazard ratio of 0.810 after accounting for activity.Compared with less muscle, greater muscle area was linked to lower relative heart failure risk, with a hazard ratio of 0.810 after accounting for activity.
Heart disease accounted for 31.6% of deaths after blocked-vessel strokes versus 15.9% after bleeding strokes, where cancer led at 38.9%.Heart disease accounted for 31.6% of deaths after blocked-vessel strokes versus 15.9% after bleeding strokes, where cancer led at 38.9%.
In 402,437 people, variants disrupting one copy of a fat-transport gene were linked to higher fatty liver odds, with an odds ratio of 3.2 versus non-carriers.In 402,437 people, variants disrupting one copy of a fat-transport gene were linked to higher fatty liver odds, with an odds ratio of 3.2 versus non-carriers.
The model scored 0.86 for distinguishing scans labeled as showing prominent fat around the heart, on a statistical measure of how well it separated groups.The model scored 0.86 for distinguishing scans labeled as showing prominent fat around the heart, on a statistical measure of how well it separated groups.
Modeled adherence to all recommendations was linked to adult diabetes risk 2.6 percentage points lower and obesity risk 5.9 percentage points lower than observed.Modeled adherence to all recommendations was linked to adult diabetes risk 2.6 percentage points lower and obesity risk 5.9 percentage points lower than observed.
Over three years, 31.0% of patients taking the drugs died, compared with 39.7% of matched patients taking neither.Over three years, 31.0% of patients taking the drugs died, compared with 39.7% of matched patients taking neither.
Diabetes prevalence rose from 15.6% in 1999–2000 to 21.4% in 2011–2012 among adults with disabilities, then leveled off near 25% in 2013–2018.Diabetes prevalence rose from 15.6% in 1999–2000 to 21.4% in 2011–2012 among adults with disabilities, then leveled off near 25% in 2013–2018.